Impaired insulin receptor function and its downregulation are the fundamental cause of several metabolic disorders, including T2DM, NAFLD, Obesity, etc (Liu et al, 2022; Li et al, 2022). This evidence concerns the gene INSR and metabolic dysfunction-associated steatotic liver disease.